| Baseline week (Day − 7 to Day − 1) | Final treatment week (Day 21 to Day 28) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SGRQ: Total | SGRQ: Activity | SGRQ: Impacts | SGRQ: Symptoms | Rescue medication use | Morning PEF | FEV1 | FEV1% predicted | SGRQ: Total | SGRQ: Activity | SGRQ: Impacts | SGRQ: Symptoms | Rescue medication use | Morning PEF | FEV1 | FEV1% predicted | |
N | 326 | 328 | 329 | 327 | 336 | 338 | 338 | 338 | 321 | 324 | 325 | 325 | 326 | 327 | 327 | 327 |
RS-Total | 0.46 | 0.43 | 0.36 | 0.39 | 0.33 | −0.30 | −0.18 | −0.17 | 0.52 | 0.54 | 0.40 | 0.43 | 0.40 | −0.27 | − 0.18 | − 0.17 |
RS-Cough and Sputum | 0.32 | 0.29 | 0.22 | 0.35 | 0.26 | −0.23 | −0.11 | − 0.11 | 0.38 | 0.36 | 0.29 | 0.44 | 0.34 | − 0.16 | − 0.11 | − 0.10 |
RS-Chest Symptoms | 0.37 | 0.32 | 0.3 | 0.33 | 0.29 | − 0.19 | −0.06 | − 0.05 | 0.45 | 0.43 | 0.37 | 0.39 | 0.32 | −0.18 | − 0.09 | − 0.08 |
RS-Breathlessness | 0.48 | 0.48 | 0.38 | 0.35 | 0.33 | −0.33 | −0.24 | − 0.22 | 0.53 | 0.59 | 0.42 | 0.38 | 0.40 | −0.31 | −0.23 | − 0.23 |
Wheeze | 0.38 | 0.33 | 0.29 | 0.41 | 0.33 | −0.12 | 0.01 | −0.11 | 0.42 | 0.38 | 0.34 | 0.43 | 0.32 | −0.12 | −0.04 | − 0.06 |